INCYTE CORP
INCYNASDAQ$116.87▲ $0.27 (+0.23%)
🌙 After hours$116.73▼ 0.12%Regular close · extended-hours price shownTrack INCY
Get earnings, price moves & breaking news on Telegram
24h▲ 0.2%
7d▲ 0.0%
14d▲ 3.2%
30d▼ 5.1%
ytd▲ 18.3%
1y▲ 29.7%
🏦Market Cap
$23.69B
Mid Cap
📈Revenue Growth (YoY)
21.2%
Healthy
📊Gross Margin
92.6%
High
💵FCF Margin
33.0%
Strong
⚖️P/S Ratio
4.1x
Fair
Otter Score
72
Strong
INCYTE CORP
INCYAnalyst Ratings
Price
$116.87
Total
44
Raised
4
Lowered
4
Avg PT
$136.53
H / L
$157 / $104
| Institution | Action | Rating | Date | Upside | |
|---|---|---|---|---|---|
TD Cowen | Reiterated | Buy | 2026-10-21 | — | — |
Truist Securities | Reiterated | Hold | 2026-10-14 | — | — |
HC Wainwright & Co. | Reiterated | Buy | 2026-10-13 | — | — |
RBC Capital | Reiterated | Sector Perform | 2026-10-08 | $114.00 | −2.50% |
Stifel | Reiterated | Buy | 2026-10-05 | — | — |
Wells Fargo | Reiterated | Equal Weight | 2026-10-01 | $107.00 | −8.40% |
JP Morgan | Reiterated | Neutral | 2026-09-28 | — | — |
Piper Sandler | Reiterated | Overweight | 2026-08-17 | $130.00 | +11.20% |
Mizuho | Reiterated | Outperform | 2026-08-04 | — | — |
Leerink Partners | Reiterated | Outperform | 2026-08-03 | $155.00 | +32.60% |
Barclays | Reiterated | Overweight | 2026-07-29 | $139.00 | +18.90% |
Guggenheim | Reiterated | Buy | 2026-07-29 | $150.00 | +28.30% |
BMO Capital | Reiterated | Market Perform | 2026-07-29 | $130.00 | +11.20% |
Morgan Stanley | Reiterated | Equal Weight | 2026-07-23 | $119.00 | +1.80% |
UBS | Reiterated | Neutral | 2026-06-26 | $127.00 | +8.70% |
Oppenheimer | Reiterated | Perform | 2026-04-29 | $152.00 | +30.10% |
Jefferies | Downgraded | Buy → Hold | 2026-03-16 | $84.00 | −28.10% |
Evercore ISI Group | Reiterated | In Line | 2026-03-05 | — | — |
B of A Securities | Reiterated | Buy | 2025-09-04 | — | — |
Citigroup | Reiterated | Buy | 2025-07-30 | $97.00 | −17.00% |
William Blair | Downgraded | Outperform → Market Perform | 2025-03-18 | — | — |
Citizens Capital Markets | Reiterated | Market Perform | 2025-03-11 | — | — |
JMP Securities | Reiterated | Market Perform | 2025-02-11 | — | — |
Cantor Fitzgerald | Reiterated | Neutral | 2025-01-10 | $79.00 | −32.40% |
Goldman Sachs | Reiterated | Neutral | 2024-10-30 | $90.00 | −23.00% |
Deutsche Bank | Reiterated | Hold | 2024-08-01 | $55.00 | −52.90% |
SVB Leerink | Reiterated | Underperform | 2023-03-20 | — | — |
Credit Suisse | Reiterated | Buy | 2023-02-16 | — | — |
Cowen & Co. | Reiterated | Outperform | 2023-02-08 | $100.00 | −14.40% |
Benchmark | Upgraded | Hold → Buy | 2021-07-20 | — | — |
Guggenheim Securities | Downgraded | Buy → Neutral | 2020-01-02 | — | — |
Nomura | Reiterated | Buy | 2019-07-31 | — | — |
Stifel Nicolaus | Reiterated | Hold | 2019-04-11 | $157.00 | +34.30% |
Argus | Reiterated | Buy | 2019-02-25 | — | — |
Argus Research | Reiterated | Buy | 2019-02-25 | $70.00 | −40.10% |
Gabelli & Co. | Upgraded | Hold → Buy | 2019-01-24 | — | — |
Leerink Swann | Reiterated | Market Perform → Perform | 2018-09-25 | — | — |
Raymond James | Upgraded | Market Perform → Outperform | 2017-09-11 | $152.00 | +30.10% |
PiperJaffray | Downgraded | Overweight → Neutral | 2017-04-17 | — | — |
SunTrust Robinson Humphrey | Reiterated | Buy | 2016-08-05 | — | — |
Brean Capital | Reiterated | Buy | 2016-02-12 | — | — |
Bank of America | Reiterated | Buy | 2015-05-29 | — | — |
Lazard | Upgraded | Neutral → Buy | 2013-01-14 | — | — |
Canaccord Genuity | Reiterated | Buy | 2012-04-26 | $152.00 | +30.10% |
Institution
TD Cowen
Reiterated · Buy · 2026-10-21
—
—
Truist Securities
Reiterated · Hold · 2026-10-14
—
—
HC Wainwright & Co.
Reiterated · Buy · 2026-10-13
—
—
RBC Capital
Reiterated · Sector Perform · 2026-10-08
$114.00
−2.50%
Stifel
Reiterated · Buy · 2026-10-05
—
—
Wells Fargo
Reiterated · Equal Weight · 2026-10-01
$107.00
−8.40%
JP Morgan
Reiterated · Neutral · 2026-09-28
—
—
Piper Sandler
Reiterated · Overweight · 2026-08-17
$130.00
+11.20%
Mizuho
Reiterated · Outperform · 2026-08-04
—
—
Leerink Partners
Reiterated · Outperform · 2026-08-03
$155.00
+32.60%
Barclays
Reiterated · Overweight · 2026-07-29
$139.00
+18.90%
Guggenheim
Reiterated · Buy · 2026-07-29
$150.00
+28.30%
BMO Capital
Reiterated · Market Perform · 2026-07-29
$130.00
+11.20%
Morgan Stanley
Reiterated · Equal Weight · 2026-07-23
$119.00
+1.80%
UBS
Reiterated · Neutral · 2026-06-26
$127.00
+8.70%
Oppenheimer
Reiterated · Perform · 2026-04-29
$152.00
+30.10%
Jefferies
Downgraded · Buy → Hold · 2026-03-16
$84.00
−28.10%
Evercore ISI Group
Reiterated · In Line · 2026-03-05
—
—
B of A Securities
Reiterated · Buy · 2025-09-04
—
—
Citigroup
Reiterated · Buy · 2025-07-30
$97.00
−17.00%
William Blair
Downgraded · Outperform → Market Perform · 2025-03-18
—
—
Citizens Capital Markets
Reiterated · Market Perform · 2025-03-11
—
—
JMP Securities
Reiterated · Market Perform · 2025-02-11
—
—
Cantor Fitzgerald
Reiterated · Neutral · 2025-01-10
$79.00
−32.40%
Goldman Sachs
Reiterated · Neutral · 2024-10-30
$90.00
−23.00%
Deutsche Bank
Reiterated · Hold · 2024-08-01
$55.00
−52.90%
SVB Leerink
Reiterated · Underperform · 2023-03-20
—
—
Credit Suisse
Reiterated · Buy · 2023-02-16
—
—
Cowen & Co.
Reiterated · Outperform · 2023-02-08
$100.00
−14.40%
Benchmark
Upgraded · Hold → Buy · 2021-07-20
—
—
Guggenheim Securities
Downgraded · Buy → Neutral · 2020-01-02
—
—
Nomura
Reiterated · Buy · 2019-07-31
—
—
Stifel Nicolaus
Reiterated · Hold · 2019-04-11
$157.00
+34.30%
Argus
Reiterated · Buy · 2019-02-25
—
—
Argus Research
Reiterated · Buy · 2019-02-25
$70.00
−40.10%
Gabelli & Co.
Upgraded · Hold → Buy · 2019-01-24
—
—
Leerink Swann
Reiterated · Market Perform → Perform · 2018-09-25
—
—
Raymond James
Upgraded · Market Perform → Outperform · 2017-09-11
$152.00
+30.10%
PiperJaffray
Downgraded · Overweight → Neutral · 2017-04-17
—
—
SunTrust Robinson Humphrey
Reiterated · Buy · 2016-08-05
—
—
Brean Capital
Reiterated · Buy · 2016-02-12
—
—
Bank of America
Reiterated · Buy · 2015-05-29
—
—
Lazard
Upgraded · Neutral → Buy · 2013-01-14
—
—
Canaccord Genuity
Reiterated · Buy · 2012-04-26
$152.00
+30.10%
One row per institution · price target from the firm's latest published target